The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Politics

Sanders targets pharma CEOs to testify in Senate, but some see ‘retaliation’ for lawsuit against Biden admin

by admin January 21, 2024
January 21, 2024
Sanders targets pharma CEOs to testify in Senate, but some see ‘retaliation’ for lawsuit against Biden admin
Read this article for free!
Plus get unlimited access to thousands of articles, videos and more with your free account!
Please enter a valid email address.
By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

Sen. Bernie Sanders, I-Vt., announced this week he plans to hold a vote on Jan. 31 to subpoena the CEOs of two big Pharma companies for a hearing on drug pricing in front of the Health, Education Labor & Pensions (HELP) Committee after they refused to testify last year.

The subpoenas for Johnson & Johnson CEO Joaquin Duato and Merck CEO Robert Davis would have them testify about why their costs for medicine are ‘substantially higher’ compared to other countries, the announcement said. 

But some executives see the pending subpoenas as a form of retaliation for a court battle over Medicare price negotiations.

‘It is absolutely unacceptable that the CEOs of Johnson & Johnson and Merck have refused an invitation by a majority of members on the HELP Committee to appear before Congress about the outrageously high price of prescription drugs,’ Sanders said. ‘These CEOs may make tens of millions of dollars in compensation. The pharmaceutical companies they run may make billions in profits.’

In November, Sanders requested Duato and Davis for testimonies on drug pricing, but they insisted that a ‘senior pharmaceutical executive best positioned to address and provide Johnson & Johnson’s position regarding the issues’ should instead appear, according to a letter Johnson & Johnson attorney Brian D. Smith sent to Sanders this week in response to the subpoena announcement. 

‘Johnson & Johnson offered to make available for the hearing the senior pharmaceutical executive best positioned to address and provide Johnson & Johnson’s position regarding the issues posed in your invitation letter,’ Smith wrote. ‘Throughout these discussions, Johnson & Johnson has also made clear its concerns with the direction the Committee is taking with the hearing, including the reasons that the company’s chief executive is not the appropriate witness for this hearing. We appreciate the opportunity to reiterate the concerns that we have previously conveyed to your staff over the past three months, and we urge you to consider permitting the Committee to hear from the appropriate executive for these topics.’

The two Pharma companies, alongside others, are currently suing to freeze Medicare drug price negotiation under Biden’s Inflation Reduction Act. Merck Executive Vice President Jennifer Zachary also sent a letter to Sanders this week suggesting the request to have the CEOs testify in front of the Senate panel is a form of ‘retaliation’ for the ongoing lawsuit.

 ‘We appreciate that many Committee members have expressed their disagreement with our lawsuit, and we respect their good-faith views. That said, your public criticisms of the Companies for challenging the IRA and comments regarding hearing witnesses indicate that the invitations to testify have been extended as retaliation for the Companies’ exercise of their constitutional right to seek relief in court,’ Zachary wrote. 

Joe Grogan, who served as a domestic policy advisor to former President Trump, told Fox News Digital in an interview that ‘CEOs are not the subject matter experts in the company who can explain all the different aspects of the pharmaceutical supply chain’ and negotiations with other governments.

‘To put a fine point on it, it’s completely un-American,’ Grogan said. ‘I mean, these companies have every right to avail themselves of the courts, they have every right to sue and to be for him to target these three companies is not a coincidence.’

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Pro-life voters reveal how they really feel about Trump’s stance on abortion
next post
Iran blames Israel for assassination of its military advisors in Damascus missile strike

Related Posts

Voters widely oppose taxpayer-funded gender surgeries, revealing Democrat...

April 15, 2025

LEE CARTER: The secret sauce of Trump’s success...

May 7, 2025

Hegseth signs ‘No More Walking on Eggshells’ policy,...

April 26, 2025

Trump attacks Iran nuclear sites: Are our troops...

June 22, 2025

Trump dishes on Milley clash over leaving military...

July 9, 2025

UN calls on countries to resume UNRWA funding...

January 29, 2024

EPA urged by state AGs to axe funds...

August 27, 2025

Kamala Harris campaign aide admits she never surpassed...

November 28, 2024

Trump super PAC launches $50m battleground state ad...

October 31, 2024

Here’s what Trump is really up to with...

April 6, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,537)
    • Investing (4,009)
    • Politics (5,328)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved